GenomeDx Signs Deals with Three PPOs | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular Diagnostics firm GenomeDx said today it has entered into agreements to provide laboratory testing as a participating provider with three preferred provider networks.

The PPOs are Stratose, Three Rivers Provider network, and Fortified Provider Network. The deals expand the number of covered lives with access to GenomeDx's Decipher prostate cancer classifier test by 62.6 million, the San Diego-based firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.